1,116
Participants
Start Date
September 23, 2019
Primary Completion Date
January 26, 2023
Study Completion Date
January 26, 2023
Etripamil NS
Participants were provided with an ambulatory Cardiac Monitoring System (CMS) to help document PSVT episodes. The CMS was self-applied by the participant, when PSVT symptoms begin. Participants self-administered etripamil NS if vagal maneuver was ineffective. After implementation of protocol amendment 2.1, participants had the option to administer a second dose of etripamil 70 mg 10 minutes after the first dose, if symptoms persisted. After an episode of PSVT where drug was administered, the participant returned to the investigative site for a study visit and was given the option to continue in NODE-303 and manage up to three subsequent episodes of PSVT with etripamil NS for a maximum of four episodes.
5129, Buenos Aires
5106, Ciudad Autonoma de Buenos Aires
5117, Ciudad Autonoma de Buenos Aires
5124, Temperley
5102, La Plata
5132, Rosario
5110, San Nicolás de los Arroyos
5134, Corrientes
5109, Salta
5116, Córdoba
5123, Córdoba
114, New York
1021, Southampton
1097, York
105, Yardley
1082, Wyomissing
1007, Salisbury
1076, Richmond
0116, Richmond
117, Lynchburg
1079, Mount Airy
129, Charlotte
1065, Charlotte
1018, Statesville
1022, Cumming
137, Macon
142, Columbus
1060, Saint Augustine
1106, Daytona Beach
1107, Edgewater
1009, Orlando
1032, Hialeah
1026, Miami
1071, North Miami Beach
1055, Miami
1064, Naples
1042, Bradenton
1012, Memphis
1062, Jackson
1024, Canton
123, Cincinnati
166, Lansing
1025, West Des Moines
1093, Saint Paul
119, Rochester
122, Rapid City
1045, Peoria
1099, Kansas City
1008, Monroe
1086, Oklahoma City
1048, Plano
1016, Fort Worth
1017, Houston
1014, San Antonio
1047, Austin
1092, Austin
5404, Barranquilla
101, Littleton
1115, Coeur d'Alene
1004, Riverton
1077, Gilbert
149, Fort Wayne
1083, West Hills
1023, Vista
5222, Canoas
1035, Stanford
1121, Fremont
1123, Corvallis
5407, Punta de Cartagena
5409, Armenia
5408, Bucaramanga
5403, San Gil
5229, Jaú
5209, Recife
5217, Brasília
1010, Bridgeport
1066, Trumbull
1078, Boston
1134, Elmer
1133, Haddon Heights
1031, Hershey
5112, Mar del Plata
5105, Mar del Plata
5115, Quilmes
5122, Ramos Mejía
5125, Buenos Aires
5118, Córdoba
5130, San Nicolás
5221, Belo Horizonte
5215, Campinas
5207, Curitiba
5227, Juiz de Fora
5214, Salvador
5219, Santo André
5212, São José do Rio Preto
5220, São Paulo
5225, São Paulo
5205, Uberlândia
5228, Belo Horizonte
5202, Campinas
5201, Goiânia
5235, Rio de Janeiro
5232, São Paulo
5204, Tatuí
5231, Votuporanga
2017, Kelowna
2010, North Vancouver
2019, Saskatoon
2018, Surrey
212, Vancouver
213, Victoria
215, Cambridge
202, Hamilton
2006, Oshawa
2001, Ottawa
2011, Greenfield Park
2020, Lévis
205, Montreal
203, Montreal
2014, Québec
2002, Saint-Jean-sur-Richelieu
2003, Saint-Jérôme
201, Sherbrooke
5401, Medellín
Lead Sponsor
Collaborators (1)
IQVIA Biotech
INDUSTRY
Milestone Pharmaceuticals Inc.
OTHER